|
Drug Topics
Community Pharmacists' Report
DrugTopics.com
March 27, 2012 |
LEGISLATIVE ACTION
A bi-partisan bill that would extend anti-trust immunity to independent pharmacies is slated for hearings before the House Judiciary Committee in Washington, D.C., later this week. » More
|
FDA NEWS
The American Pharmacists Association and the National Community Pharmacists Association supported a new nonprescription class of drugs at FDA’s public hearing last week. » More
|
FDA has approved alendronate sodium (Binosto, EffRx Pharmaceuticals) effervescent tablets, the first effervescent osteoporosis treatment in a buffered solution. » More
|
CONTINUING EDUCATION
Of the 35 new molecular entities approved by FDA in 2011, 17 are considered groundbreaking because of their potential to make a real difference in the lives of patients.
To read and print the article with TEST QUESTIONS, click here. To proceed to the online exams and earn up to 2 CPE credits, click here to login.
|
GENERICS NEWS
Amneal Pharmaceuticals has launched escitalopram oxalate oral solution in 5 mg/5 mL strength, the first generic of antianxiety/antidepressant Lexapro (Forest) in liquid form on the market. » More
|
CHAINS AND BUSINESS
Walgreens recently added a mobile coupon service available through social media service foursquare, following the launch of new prescription mobile apps. » More
|
ASSOCIATION NEWS
A New York community pharmacist highlighted the problem of mail-order waste after a man turned in $30,000 worth of medications to the pharmacy. » More
|
Pharmacists and pharmacy advocates conducted more than 350 meetings with U.S. senators and representatives on Capitol Hill last week during RxIMPACT Day, sponsored by the National Association of Community Drug Stores. » More
|
Survey
a) Yes, my employer allows PharmD after my name or the use of the title Dr. before my name.
b) Yes, my employer allows PharmD after my name but not the title Dr. before my name.
c) No, my employer does not allow any doctor title before or after my name.
Respond here and see what your colleagues think, too.
Want to see the results of our last survey about whether pharmacists should have the authority to prescribe medications? Click here.
|
|
Confirm your
e-newsletter subscription click here.
To ensure future delivery of email newsletters from Drug Topics please take a moment to confirm your subscription by clicking here.
Thank you,
Drug Topics Staff |
Digital Edition |
|
|
|
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To ensure delivery to your inbox, please add us to your address book. If you need help doing this, Click here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or
fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
|